Roberto Scalamogna @scrapizz

milano Joined July 2012

Tweets

277
Followers

97
Following

266
Likes

27

Fabio Puglisi @puglisi_fabio

5 years ago

@curijoey @IEOufficiale @LaStatale Chapeau!

0 1 1 0 0

Roberto Scalamogna @scrapizz

6 years ago

UK Government: Start an Immediate UK trial for Chloroquine and Hydroxy-Chloroquine as a treatment for Covid-19 (Coronavirus) - Firma la petizione! chng.it/7sdSwhWW via @ChangeItalia

0 0 0 0 0

NEJM @NEJM

6 years ago

Case report shared: A case of SARS-CoV-2 infection complicated with severe ARDS. Read about lessons learned. @NEJMres360 #COVID19 #SARSCoV2

9 508 787 0 49

Andrea Necchi @AndreaNecchi

6 years ago

Come to the Poster Discussion session #ASC02019 to see the @FoundationATCG data on #bladdercancer @ASCO

0 6 18 0 0

Download Image

The promise of #PersonalisedHealthcare is finding the right treatment for every patient. We are committed to fulfilling that promise together with partners like Syapse, Foundation Medicine and Flatiron. Read more. #ehealth #datascience ow.ly/YfNU50utLg2

0 5 19 0 0

Download Video

Foundation Medicine @FoundationATCG

6 years ago

An analysis of 2k+ primary & metastatic urothelial cancer cases found that 48% of all patients harbored genomic alteration that may benefit from approved or investigational targeted therapies.

3 21 68 0 1

Oncoinfo @Oncoinfo_it

6 years ago

#ASCO19 | In quale direzione ci sta portando la tecnologicizzazione dell'oncologia? Come condividere con i pazienti l'enorme mole di informazioni e gli strumenti messi a disposizione dai nuovi modelli mutazionali? Ne abbiamo parlato con Paolo Marchetti: bit.ly/2IfcHTK

0 1 0 0 0

Download Image

Oncoinfo @Oncoinfo_it

6 years ago

#ASCO19 | La personalizzazione della cura sta rivoluzionando anche la ginecologia oncologica: quale impatto ha (o dovrebbe avere) questo nuovo approccio da parte dei clinici sulla vita delle pazienti? Ce ne ha parlato @ketta_lorusso: bit.ly/2Z6kgmp #gyncsm

0 1 0 0 0

Download Image

Oncoinfo @Oncoinfo_it

6 years ago

#ASCO19 | L’edizione 2019 si caratterizza per una forte assunzione di responsabilità da parte dei vertici dell'@ASCO in merito al problema dell’iniquità di accesso all’innovazione terapeutica. Il commento di Roberto Bordonaro: bit.ly/2WkT8TT

0 1 1 0 1

Download Image

Oncoinfo @Oncoinfo_it

6 years ago

#ASCO19 | I dati di chiusura dello studio #CLEOPATRA su #pertuzumab in prima linea nel trattamento delle pz con carcinoma mammario HER2+ metastatico confermano quelli delle analisi precedenti. Il commento di Michelino De Laurentiis: bit.ly/2QM0x8W #bcsm @istitutotumori

0 1 0 0 0

Download Image

Oncoinfo @Oncoinfo_it

6 years ago

#ASCO19 | Risultati entusiasmanti quelli relativi all’utilizzo di #entrectinib nell’ambito dei tumori pediatrici, inclusi (per la prima volta) quelli cerebrali. Ne abbiamo parlato con Michela Casanova: bit.ly/313Fi76 @IstTumori #pedcsm

0 1 0 0 0

Download Image

Oncoinfo @Oncoinfo_it

6 years ago

.@PAscierto: #ASCO19 few new data in #melsm and several confirmations, one is from #COLUMBUS @OmidHamidMD @Melanoma_doctor @jasonlukemd @alexshoushtari @FunchainMD

0 2 5 0 0

Download Video

Marina Garassino @marinagarassino

6 years ago

I am personally convinced that we have several therapeutic options to modulate TME with metabolism. #cholesterol #immunometabolism #cholesterol #macrophages #Immunotherapy #NSCLC @OncoAlert Membrane Cholesterol Regulates Macrophage Plasticity in Cancer cell.com/cell-metabolis…

0 3 7 0 1

Oncoinfo @Oncoinfo_it

6 years ago

#ASCO19 Paolo Marchetti sul ruolo dell’oncologo nell’umanizzazione del percorso terapeutico @oncoblogger @SCinieri @EIannelli @AIOMtweet @AiomFondazione

1 3 8 0 0

Download Video

Roche @Roche

6 years ago

#DYK that tumour-agnostic treatments target specific genes within a person’s #cancer, regardless of where the tumour is located in the body? Learn more about this paradigm-shifting approach here: ow.ly/w4pS50uqRVS

14 117 339 0 21

Download Gif

G Curigliano MD PhD @curijoey

6 years ago

#OncoAlert #ASCO19 @LaStatale @IEOufficiale @darioT_ @AntonyMarra @PTarantinoMD @APassaroMD ASCO 2019 in summary: 1) Big data to move from evidence based to real life evidence cancer medicine. 2) The revival of precision Medicine in many diseases. 3) Immunotherapy at plateau!

1 14 31 0 1

Paolo A. Ascierto @PAscierto

6 years ago

Thank you Dr Hamid @OmidHamidMD for giving this amazing overview about anti-PD1/PD-L1 treatments in cancers diseases @ASCO @jasonlukemd @Oncoinfo_it

0 2 3 0 0

Download Image

Foundation Medicine @FoundationATCG

6 years ago

Real-world data from our clinico-genomic database with @flatironhealth show that looking at both #TMB and PD-L1 may help predict response to immunotherapy better than either alone in #NSCLC (abstract 2630). Read this @ASCO abstract & others here: bit.ly/2MstzvO

0 5 19 0 1

Download Image

Foundation Medicine @FoundationATCG

6 years ago

At #ASCO19, we'll be presenting a study evaluating potential immunotherapy biomarkers like TMB & others known in other tumor types, in 3 sub-types of metastatic #breastcancer. These insights may help guide new research in this area. View our abstracts: bit.ly/FMIASCO19

0 3 7 0 0

Download Image

GA4GH @GA4GH

7 years ago

#Genomic data sharing has the power to accelerate scientific discoveries. In celebration of National #DNADay19, here's why genomic data sharing is important to advancing human health: